M U Helber|C Ulrich - JoVE Visualize

Showing results (171-180 of 233) with videos related to

Pageof 24

Sort By:

Science (New York, N.Y.)|December 9, 2017

Structural basis for methylphosphonate biosynthesisDavid A Born, Emily C Ulrich, Kou-San Ju, et al.

Bioorganic & Medicinal Chemistry|February 2, 2010

Structural analogues of schweinfurthin F: probing the steric, electronic, and hydrophobic properties of the D-ring substructureNatalie C Ulrich, John G Kodet, Nolan R Mente, et al.

Science (New York, N.Y.)|January 26, 2002

Magnetic resonant mode in the single-layer high-temperature superconductor Tl2Ba2CuO(6+delta)H He, P Bourges, Y Sidis, et al.

Physical Review Letters|February 3, 2004

Magnetism, charge order, and giant magnetoresistance in SrFeO(3-delta) single crystalsA Lebon, P Adler, C Bernhard, et al.

Kidney International|December 28, 2007

CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patientsG H Heine, C Ulrich, E Seibert, et al.

Chemosphere|October 12, 2013

Indigenous microbes survive in situ ozonation improving biodegradation of dissolved organic matter in aged oil sands process-affected watersLisa D Brown, Leonidas Pérez-Estrada, Nan Wang, et al.

Shock (Augusta, Ga.)|May 1, 1996

Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trialA M Froon, J W Greve, W A Buurman, et al.

Intensive Care Medicine|September 1, 1996

Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilatorF S Leijten, A W De Weerd, D C Poortvliet, et al.

Critical Care Medicine|March 12, 2019

Toward Gender Equity in Critical Care Medicine: A Qualitative Study of Perceived Drivers, Implications, and StrategiesJeanna Parsons Leigh, Chloe de Grood, Sofia B Ahmed, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 30, 1998

Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agentJ A Martiney, A J Rajan, P C Charles, et al.

Pageof 24

Showing results (171-180 of 233) with videos related to

Sort By:

Pageof 24

Science (New York, N.Y.)|December 9, 2017

Structural basis for methylphosphonate biosynthesisDavid A Born, Emily C Ulrich, Kou-San Ju, et al.

Bioorganic & Medicinal Chemistry|February 2, 2010

Structural analogues of schweinfurthin F: probing the steric, electronic, and hydrophobic properties of the D-ring substructureNatalie C Ulrich, John G Kodet, Nolan R Mente, et al.

Science (New York, N.Y.)|January 26, 2002

Magnetic resonant mode in the single-layer high-temperature superconductor Tl2Ba2CuO(6+delta)H He, P Bourges, Y Sidis, et al.

Physical Review Letters|February 3, 2004

Magnetism, charge order, and giant magnetoresistance in SrFeO(3-delta) single crystalsA Lebon, P Adler, C Bernhard, et al.

Kidney International|December 28, 2007

CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patientsG H Heine, C Ulrich, E Seibert, et al.

Chemosphere|October 12, 2013

Indigenous microbes survive in situ ozonation improving biodegradation of dissolved organic matter in aged oil sands process-affected watersLisa D Brown, Leonidas Pérez-Estrada, Nan Wang, et al.

Shock (Augusta, Ga.)|May 1, 1996

Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trialA M Froon, J W Greve, W A Buurman, et al.

Intensive Care Medicine|September 1, 1996

Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilatorF S Leijten, A W De Weerd, D C Poortvliet, et al.

Critical Care Medicine|March 12, 2019

Toward Gender Equity in Critical Care Medicine: A Qualitative Study of Perceived Drivers, Implications, and StrategiesJeanna Parsons Leigh, Chloe de Grood, Sofia B Ahmed, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 30, 1998

Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agentJ A Martiney, A J Rajan, P C Charles, et al.

Pageof 24